Crispina Calsada

Insider Reports History

Entity
Individual
Location
C/O Ambrx, Inc., 10975 N. Torrey Pines Rd., La Jolla, CA
Signature
Christopher Aker, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Crispina Calsada:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Chief Financial Officer Common Stock 5.78K $6.88K $1.19 Jan 18, 2024 Direct
Regulus Therapeutics Inc. Chief Financial Officer Stock Option (Right to Buy) 462K May 20, 2024 Direct

Insider Reports Filed by Crispina Calsada

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGLS Regulus Therapeutics Inc. May 20, 2024 1 $0 4 May 21, 2024 Chief Financial Officer
RGLS Regulus Therapeutics Inc. Jan 18, 2024 1 -$6.51K 4 Jan 18, 2024 Chief Financial Officer
RGLS Regulus Therapeutics Inc. Jan 12, 2024 2 $0 4 Jan 17, 2024 Chief Financial Officer
RGLS Regulus Therapeutics Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 Chief Financial Officer
RGLS Regulus Therapeutics Inc. Jan 11, 2023 1 $0 4 Jan 17, 2023 Chief Financial Officer
RGLS Regulus Therapeutics Inc. May 10, 2022 1 $0 4 May 11, 2022 Chief Financial Officer
RGLS Regulus Therapeutics Inc. Jan 12, 2022 1 $0 4 Jan 26, 2022 Chief Financial Officer